-
Medication-Assisted Treatment is a Cost-Effective Strategy for the Treatment of Opioid Use Disorder
The researchers sought to assess the cost-effectiveness of OUD treatments and association of treatments with outcomes in the United States.
The post Medication-Assisted Treatment is a Cost-Effective Strategy for the Treatment of Opioid Use Disorder appeared first on Psychiatry Advisor.
-
European Clinical Practice Recommendations Offer Guidance for Opioid Use in Chronic Pain
The European Clinical Practice Recommendations were developed to support good decision making and, when needed, appropriate prescribing of opioids for patients of any age with chronic noncancer pain.
The post European Clinical Practice Recommendations Offer Guidance for Opioid Use in Chronic Pain appeared first on Psychiatry Advisor.
-
NIH Lessons Learned: The Impact of the COVID-19 Pandemic on Those Struggling With Substance Use Disorders
Francis Collins, MD, PhD, director of the NIH recently spoke with Nora Volkow, MD, director of NIH’s National Institute on Drug Abuse (NIDA), about the impact of the COVID-19 pandemic on people struggling with substance use disorders and those who are trying to help them.
The post NIH Lessons Learned: The Impact of the COVID-19 Pandemic on Those Struggling With Substance Use Disorders appeared first on Psychiatry Advisor.
-
Majority of E-Cigarette Users Want to Quit
A majority of electronic cigarette users express interest in eventually quitting vaping.
The post Majority of E-Cigarette Users Want to Quit appeared first on Psychiatry Advisor.
